{
    "Trade/Device Name(s)": [
        "SmartLink GOLD Blood Glucose Monitoring System",
        "SmartLink\u2122M GOLD Blood Glucose Meter",
        "SmartLink\u2122M GOLD Test Strip",
        "SD Control Solutions Level M and Level H"
    ],
    "Submitter Information": "Standard Diagnostics, Inc.",
    "510(k) Number": "K100398",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082683"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "May 7, 2010",
    "Summary Letter Received Date": "May 10, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Lancet",
        "Lancing device"
    ],
    "Instrument(s)/Platform(s)": [
        "SmartLink\u2122M GOLD Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Blood glucose monitoring"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for SmartLink GOLD Blood Glucose Monitoring System for monitoring glucose in capillary whole blood by professional or home use",
    "Indications for Use Summary": "Indicated for monitoring glucose in fresh capillary whole blood from fingertip, palm, forearm, or upper arm as an aid to monitor diabetes control at home or in clinical settings; not for screening, diagnosis, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}